Cystic fibrosis (CF) is the most common lethal inherited disease in the Caucasian population with an incidence of -1 in 2,500 live births. Pulmonary complications of CF, which are the most morbid aspects of the disease, are caused by primary abnormalities in epithelial cells that lead to impaired mucociliary clearance. One potential therapeutic strategy is to reconstitute expression of the CF gene in airway epithelia by somatic gene transfer. To this end, we have developed an animal model of the human airway using bronchial xenografts and have tested the efficiency of in vivo retroviral gene transfer. Using the LacZ reporter gene, we find the efficiency of in vivo retroviral gene transfer to be dramatically dependent on the regenerative and mitotic state of the epithelium. Within an undifferentiated regenerating epithelium in which 40% of nuclei labeled with BrdU, 5-10% retroviral gene transfer was obtained. In contrast, no gene transfer was noted in a fully differentiated epithelium in which 1% of nuclei labeled with BrdU. These findings suggest that retroviral mediated gene transfer to the airway in vivo may be feasible if the proper regenerative state can be induced. (J. Clin. Invest. 1992. 90:2598-2607
Introduction
Cystic fibrosis (CF)' is an inherited disease that affects several organ systems. The pulmonary manifestations of CF, which are believed to be caused by defects in mucociliary clearance, are the most morbid manifestations ofthe disease (1) . Isolation of the gene responsible for CF suggested possible therapeutic strategies based on lung-directed somatic gene transfer (2, 3, 4) . Functional correction ofthe defect in cultured CF cells by viral transduction of a gene encoding a normal version of the cystic fibrosis transmembrane conductance regulator (CFTR) provided support for the feasibility of this approach (5, 6) .
Rational development of somatic gene therapies for CF requires a better understanding of the distribution of CF gene expression in the human lung. Experience with the clinical manifestations and pathologic consequences of CF strongly suggests that the cells of the airway are directly involved in pathogenesis (1) . Several studies have supported this hypothesis, including our recent characterization of normal human bronchus, which localized CFTR RNA and protein to both the surface epithelium and submucosal glands (6a). The surface epithelium is affected by CF (7, 8) and has features that make it an attractive but challenging target for direct gene transfer. It may be possible to achieve efficient access ofgene transfer substrates to the surface cells ofthe airway through relatively noninvasive means such as aerosol inhalation or bronchial lavage. However, the surface epithelium is a complex structure that normally has a low level of cell cycling (9) .
Several approaches for delivering genes to the airway have been proposed including retroviruses (6, 10, 11) , adenoviruses (12) , adeno-associated viruses (13, 14) , and liposomes (15) . While each has its potential advantages, no single approach has emerged as a method of choice for CF. The largest experience in other models of gene therapy has been with retroviruses.
Many animal models (16) (18, 19 ). An important consideration in the application of retroviruses to in vivo airway gene transfer relates to the extensive experience with these reagents in other models and their relative safety. Disadvantages include relatively low viral titers and the presumed requirement for active replication ofthe recipient cell to achieve gene transduction.
Critical to the development of effective gene therapies of CF is the availability of animal models to evaluate the feasibility, efficacy, and safety of the various approaches. Epithelial cells derived from the airway of a variety of animals have been shown to develop into fully differentiated epithelia after they are seeded onto denuded trachea and implanted into nu/nu mice (20, 21) . Our initial attempt at using the xenograft system for studying gene transfer was based on the reconstitution of denuded trachea with rat tracheal cells exposed to retroviruses while in primary culture (10) . Grafts seeded with the genetically modified cells developed a fully differentiated epithelium with patches oftransgene expressing cells possibly representing clonal outgrowth of retroviral transduced progenitor cells. We report in this study a xenograft animal model based on the generation of a fully differentiated human epithelium in athymic mice. This model was used to assess the potential ofretroviruses for delivering recombinant genes into the human airway.
Methods
Epithelial cell isolation and culture. Human bronchial tissue (three different bronchial samples were analyzed) was obtained from healthy donor lungs at the time of lung transplantation. Primary cultures were prepared according to a previous protocol with modifications (22) . The tissue was soaked and rinsed in modified Eagle's medium containing 50 U/ml penicillin, 50 Ag/ml streptomycin, 40 Mg/ml tobramycin, 50 jig/ml ceftazidime, 2.5 jg/ml amphotericin B, 10 5 ;g/ml transferrin, 25 ng/ml epidermal growth factor, 3.75 ,ug/ml endothelial cell growth supplement, 10 ng/ml cholera toxin, 50 U/ml penicillin, 50 ;g/ml streptomycin, 40 ,g/ml tobramycin, 50 ug/ml ceftazidime, and 2.5 Ag/ml amphotericin B, and plated at a density of 2 X 106 cells per 100-mm plate (uncoated plastic). The medium on cultures was replaced every 24 h. Cultures were harvested on day 4 by treatment of 0.1% trypsin followed by the addition of 10% FCS/Ham's F12. Cells were pelleted and resuspended in hormonally defined medium for seeding into denuded rat tracheas.
Establishment of xenografts. Donor rat tracheas were harvested from CO2 asphyxiated male Fisher 344 rats (200-250 g) and denuded by three rounds offreeze thawing followed by rinsing ofthe lumen with modified Eagle's medium. Tracheas were ligated to tubing at both ends after seeding of 2 x I04 or 2 x 106 primary bronchial epithelial cells in 30 ;d of hormonally defined medium. These "open-ended" grafts were then inplanted subcutaneously in the flanks of female nu/nu BALB/c mice anesthetized by intraperitoneal injections of 100 mg/kg ketamine and 20 mg/kg xylazine. Implants were sutured such that the ends ofthe tubing exited through the back of the neck (Fig. 1 A) . Grafts were flushed weekly with Ham's F12 to remove excess mucus.
Analysis ofgrafts by electron microscope. Xenografts were excised rinsed briefly in PBS followed by overnight fixation in 2.5% glutaraldehyde, 1.5% paraformaldehyde, 0.02% CaCl2 in 0.1 M sodium cacodylate (pH 7.4) at 4°C. After fixation, the tissue was washed repeatedly in 0.1 M sodium cacodylate, postfixed in 1% osmium tetroxide (1 h at 0°C), dehydrated in alcohols, and embedded in epoxy resins. Sections were stained with uranyl acetate and lead citrate before being viewed and photographed in an electron microscope (model 1 I a; Hitachi Sci. Instrs., Mountain View, CA).
BrdU labeling and detection ofmitotically active cells. Mitotically active cells were labeled at the time of BAG retroviral infection by the addition of 50 jg/ml 5-bromo-2'-deoxyuridine-5'-monophosphate (BrdU) to the retroviral medium. Grafts seeded with 2 X 104 and 1 X 106 cells were labeled with BrdU at 1 and 4 wk after transplantation, respectively. Infections were performed in the presence of BrdU for 24 hrs after which the tracheas were flushed with 2 ml F12 medium followed by expulsion of all fluid from the lumen of the graft with air. Grafts were harvested 3 d after infection and fresh frozen in optimal cutting temperature embeding compound. Sections (4-rm) were fixed in methanol for 10 min at -20°C followed by air drying. Sections were then treated with 2 N HC1 for 1 h at 37°C and neutralized in 0.1 M NaBorate pH 8.5 for 10 min. After rinsing in PBS for 10 min, sections were blocked in 20% donkey serum (DS)/PBS for 30 min. Mouse antiBrdU-FITC conjuagated monoclonal antibody (Boehringer Mannheim Corp., Indianapolis, IN) was incubated with the sections (50 Mg! ml) in PBS containing 1.5% DS for 90 min at room temperature. Sections were washed in 1.5% DS/PBS and coverslipped in mounting medium (Citifluor Inc., London, England). Colocalization oflacZ positive cells with BrdU label was not possible because of HCI destruction of anti-lacZ reactive epitopes.
The percent of BrdU labeling was calculated by counting 30,000 cells (as evident by nuclei under Nomarski optics) from 12 different sections of two fully differentiated grafts and 3,000 cells from 12 sections of two regenerating grafts. The averages and standard deviations of this analysis are reported in the text.
Localization of cell specific cytokeratins and CFTR. Fresh frozen xenograft tissue was sectioned at 6 Mm onto poly(L-lysine)-coated slides and fixed in acetone for 10 min at -20'C followed by air drying. Sections were blocked in 20% DS in PBS for 30 min followed by the addition of the following primary antibodies for 90 min. CFTR was localized by indirect double immunofluorescence using an affinity purified rabbit polyclonal antibody to a COOH-terminal peptide (residues 1468-1480) of CFTR (23, 24, 25) . This previously characterized antibody is designated a-1468 and shows reactivity in normal bronchial epithelium in a subset of keratin-14 positive cells (6 a). Cytokeratin-14 (RCK107) and cytokeratin-18 (RGE53) monoclonal hybridoma supernatants were kindly provided by Dr. Frans Ramekers University of Limburg, Maastricht, The Netherlands and have been previously characterized (26, 27) . Hybridoma supernatants were used undiluted and a-1468 was used at a concentration of 5,g/ml. After primary antibody incubation the sections were washed three times and incubated with 5 ttg/ml of FITC-anti-mouse or FITC-anti-rabbit for 30 min. Sections were washed and coverslipped in mounting medium.
Peptide competition experiments were performed with a-1468 by preincubating 0.5 mg/ml peptide (residues 1468-1480 of CFTR protein) with 0.25 mg/ml of a-1468 in PBS containing 1.5% DS overnight at 4°C before immunofluorescent staining. Control uncompeted antibody was incubated under the same conditions but without peptide.
Production of virus and retroviral infection. Previously described amphotropic packaging cell lines harboring the BAG lacZ containing provirus (28) and low density lipo-protein receptor containing provirus (29) were grown in DME containing 10% FCS and 1 Ag/ml penicillin/ streptomycin. In the BAG construct lacZ is expressed from the viral long terminal repeat. Virus was harvested from a confluent monolayer of cells by the addition of fresh medium for 18 h. After harvesting, stocks were supplemented with 3 Ag/ml polybrene and passed through 0.2-,gm filters. Viral stocks were used fresh for direct infusion into xenografts. Xenografts were exposed to 1 ml of retrovirus by slow infusion for I h in all cases except for retroviral infection in the presence of BrdU in which the lumen of the grafts were filled with virus and incubated for 24 h. After infection, grafts were rinsed with 2 ml of Ham's F12 followed by expulsion of all fluid from the graft with air.
Analysis ofgraftsfor expression oflacZ. Xenografts were cytochemically analyzed for lacZ transgene expression using a previously described protocol (10) . At various times after retroviral infections xenografts were excised from euthanized mice and directly fixed in 0.5% glutaraldehyde/PBS for 10 min followed by rinsing in 1 mM MgClJ/ PBS for two 15-min washes. Xenograft rings were then stained in Xgal solution (10) for 4 h. Tissue was then rinsed in PBS and postfixed in 4% paraformaldehyde/PBS overnight before embedding in glycomethacrylate by standard protocol.
Results and Discussion
Epithelial cells derived from main stem bronchi of donor organs were plated in culture and subsequently harvested and seeded onto denuded rat trachea that were implanted into nu/ nu mice. Several problems were encountered in our initial experiments. When ligated at both ends, the implanted tracheas accumulated increasing quantities ofmucus that eventually led to distortion ofthe graft. After 3-6 wk incubation, the reconstituted epithelium contained major areas of a squamous or cuboidal epithelium, as well as pseudostratified morphology. To prevent the intraluminal accumulation of mucus and provide easy access to the xenograft, we modified the system in the following manner. The ends of the implanted tracheas were kept open to the surface via plastic tubing that was tied to the proximal and distal ports of the graft, tunneled subcutaneously, and exited percutaneously. Fig. 1 A illustrates this modification. Xenografts established using this technique were irrigated regularly with isotonic buffer to prevent accumulation of mucus. The resulting fully mature graft produced a pseudostratified epithelium along the entire surface of the the trachea that was indistinguishable from that ofa normal bronchus. An electron micrograph of a typical xenograft is presented in Fig. 1 Analysis ofmorphology andproliferative activity ofregenerating and differentiated grafts. Light microscopic analysis of grafts seeded at low density revealed relatively undifferentiated morphology. Cells were either squamous or cuboidal in shape and were frequently stratified into multiple layers. Approximately > 95% of the cells reacted with antibodies for the basal cell specific marker keratin-14 ( Fig. 2 A) , while infrequent squamous cells lining the lumen of this cuboidal epithelium (< 2% of total cells) reacted with a cytokeratin-18 antibody (Fig. 2 B) . None ofthe cells appeared to polarize, contain cilia, or react to alcian blue or periodic acid-Schiff (data not shown). When grafts seeded at low density were incubated with BrdU to assess the overall state of cell proliferation at the time of retroviral infection, 40±4% of the cells were mitotically active (Fig.  3 A) . These studies indicate that after 1 wk, grafts seeded with 2 x 104 cells contain an undifferentiated epithelium that is rapidly regenerating (subsequently referred to as regenerating grafts). If left in the nu/nu mice for 6 wk, these grafts became quiescent and fully differentiated (Fig. 5 B) .
Grafts seeded at high density (2 X 106 cells) develop a fully differentiated epithelium within 3 wk. The pattern of staining seen in fully differentiated grafts with the basal cell specific keratin-14 antibody (Fig. 2 C) and the keratin-18 antibody (Fig. 2 D) , which is specific for differentiated columnar cells, was equivalent to the pattern of staining in normal human bronchus (data not shown) and that reported in other species such as rat (26, 27) . In addition to characterizing the pattern of cytokeratin staining, we felt it was important to compare the localization of CFTR in the fully differentiated graft to normal human bronchus, since this xenograft system will be used as a model for studying CF gene therapies. Fig. 2 E shows the pattern of staining within a fully differentiated graft to a polyclonal antibody made to the COOH terminus of CFTR. This pattern is virtually identical to that seen in normal human bronchial samples (6 a), and is competed by preincubation of the antibody with peptide (Fig. 2 F) . Low level staining is detected on the apical surface ofcolumnar epithelial cells, while a higher level of staining is seen in basal and intermediate cells. Incubation of these grafts with BrdU resulted in labeling of 1.1±0.2% of the cells (Fig. 3 B) , a number similar to that found in the bronchi ofseveral types ofanimals including rat and mouse (9) . We conclude that after 3 wk, grafts seeded at high density produce an epithelium that closely resembles that of a normal, unperturbed human main stem bronchus (subsequently referred to as differentiated grafts).
Analysis of retroviral gene expression in regenerating and differentiated grafts. Regenerating grafts were exposed to lacZ retrovirus and subsequently analyzed histochemically for retroviral gene expression. Analysis of grafts 3 d after infection revealed lacZ expression in 5-10% of the reconstituted epithelium (Figs. 4 A and 5 A) . Expression of lacZ was demonstrated in cells located throughout the depth of the apparently undifferentiated stratified epithelium (Fig. 5 A) 4 C and 5 C) . These studies demonstrate the feasibility ofdirectly delivering recombinant genes to a human airway epithelium with retroviruses. The efficiency of gene transfer into an undifferentiated regenerating epithelium was only 5-10-fold less than that achieved when the same virus was exposed to a rapidly dividing culture of murine fibroblasts for 12 h (data not shown). Importantly, the transgene continued to express for the life of the xenograft (5 wk after exposure to virus) and was distributed in all cell types (Figs. 4 B and 5 B) . In contrast, retroviral mediated gene transfer into a quiescent, fully differentiated graft was remarkably inefficient (Figs. 4 C and 5 C).
This may be explained in part by the extremely low numbers of dividing cells in these graft at the time ofexposure to virus. The requirement of cell division for retroviral-mediated gene transfer has been demonstrated in vitro using cultured diploid fibroblasts (30) . Other factors may have contributed to the low efficiency of gene transfer in the differentiated grafts including diminished expression of the receptor for the amphotropic virus or localization of the receptor to inaccessible areas of the cell such as intracellular compartments or the basolateral sur- % t, face. It is impossible to study these potential mechanisms because the amphotropic virus receptor has not been identified. The important challenge is to translate these observations in the xenografts to practical approaches of gene transfer into the airway in vivo. These data strongly suggest that it will be necessary to significantly perturb the biology of the airway in order to achieve significant levels ofgene transfer. Various models of airway injury have been described which lead to compensatory increases in the proliferation of various cell types of the upper airway including basal cells and various secretory cells (9) . These usually involve transient exposure to noxious stimuli such as toxic chemicals, mechanical irritation, or viral pathogens. The clinical feasibility of these interventions remains to be demonstrated. Alternatively, it may be possible to deliver genes via retroviruses to the undifferentiated epithelium of fetuses in utero, circumventing the need for airway injury in the adult. The relevance of the regenerating graft to models of airway injury and the feasibility of accomplishing gene transfer in an endogenous airway must await additional studies in animals. In addition, it is not clear ifthe efficiency ofgene transfer accomplished in the undifferentiated graft (i.e., 5-10%) would be sufficient to achieve a therapeutic effect. Boucher et al. (31 ) have achieved significant functional correction in a polarized monolayer of CF cells when only 10% of the cells have been corrected by gene transfer.
In summary we describe an animal model for evaluating the feasibility and potential efficacy of somatic gene therapies for CF. Our results support the use ofrecombinent retroviruses in these therapies ifthe recipient airway epithelium is relatively undifferentiated and rapidly regenerating.
